In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).
We know the profound impact this recall has had on our patients, our business customers, and clinicians – which is why we’ve created tools and resources that can offer support throughout this process. You can find these materials on our Patient, Business customer, and Clinician pages.
We aim to complete the repair and replacement program for the majority of registered patients by December 2022. While we are making progress, we realize that for patients waiting for a repaired or replaced device, progress can’t come fast enough.
We are committed to sharing regular updates on our efforts via this website, monthly emails to registered patients and social media, including timing specific to when you will receive your replacement device(s).
(Emergency Use Authorization)
Also known as DreamStation BiPAP autoSV
Also known as DreamStation BiPAP AVAPS, DreamStation BiPAP S/T
Also known as System One BiPAP autoSV, System One BiPAP autoSV Advanced
Also known as System One BiPAP AVAPS (C-Series), System One BiPAP S/T (C-Series)
In-Lab Titration Device
Also known as BiPAP Hybrid A30Ventilator (A-Series)
(not marketed in US)
Also known as BiPAP V30 Auto Ventilator (A-Series)
Also known as BiPAP A40 Ventilator (A-Series)
(not marketed in US)
Also known as BiPAP A30 Ventilator (A-Series)
(not marketed in US)
If your device is affected...
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.